Soligenix, Inc. (SNGX) Financials
SNGX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 6.9 million | 3.8 million |
| Dec. 31, 2025 | 9.2 million | 3.9 million |
| Sept. 30, 2025 | 11.3 million | 3.7 million |
| June 30, 2025 | 5.8 million | 3.9 million |
SNGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -2.4 million | ? |
| Dec. 31, 2025 | -2.7 million | 320125 |
| Sept. 30, 2025 | -2.9 million | 104346 |
| June 30, 2025 | -2.7 million | 99513 |
SNGX Net Income
No data available :(
SNGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 6.0 million | 213425 | - |
| Dec. 31, 2025 | 7.9 million | - | 358144 |
| Sept. 30, 2025 | 10.5 million | - | 385054 |
| June 30, 2025 | 5.1 million | - | 411403 |
SNGX Shares Outstanding
SNGX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 3 | 1.8 million | 1.1 million | - |
| Dec. 31, 2025 | 3925 | 2.3 million | 1.2 million | - |
| Sept. 30, 2025 | 608 | 1.6 million | 996604 | - |
| June 30, 2025 | 3317 | 1.7 million | 1.1 million | - |
SNGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 1098 |
| Dec. 31, 2025 | - | 1000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 703 |
SNGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
SNGX
Price: $0.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.14 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16498
Ebitda: -951647Market Capitalization: 4.6 million